Migraine Headaches--Treatment and Prevention Flashcards

1
Q

Migraine–neural events provoke

A

-dilation of cranial blood vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Goal of therapeutic agents

A

-rescue patient from start of a migraine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Medication taken in prodrome phase

A
  • Triptans–5HT1B/1D Receptor agonists

- Ergot alkaloids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Medications taken in headache phase

A
  • NSAIDS

- Acetaminophen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Preventative agents

A

-B blockers
-Tricyclic antidepressants
-anticonvulsants
-Ca channels
(given in asymptomatic phase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

neurogenic inflammation theory of migraine

A

-wave of electrical cavity
-stimulates release of neuropeptides (CGRP, substance P) and inflammatory mediators
(NO, histamine, prostaglandins)
-dilate cranial blood vessels and sensitive nerves to pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

step 1

A
  • brainstem dysfunction sparks a wave of excitation/depression in Cortex–H, K, NO discharge from neurons
  • cerebral vasoconstriction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

step 2

A
  • electrolytes and NO diffuse and dilate cranial arteries and depolarize perivascular trigeminal terminals
  • CGRP and neuropeptides promote neurogenic inflammation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

step 3

A

neurogenic inflammation irritates TG n and transmits migraine pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

2 key mediators–interact throughout trigeminal neuromuscular system

A

-CGRP and NO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

used to treat coronary a disease

A
  • Organic nitrates (NO)

- Can provoke migraine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

cranial vessels–R

A

5HT-1B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

peripheral neuron R

A

5HT-1 D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

central neuron R

A

-5HT 1B/iD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

serotonin receptor-vascular and synaptic

A
  • vascular-5HT1B R

- synaptic-5HT 1 D R

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Triptans mechanism

A
  • selective 5HT1D/1B receptor agonist
  • 5HT-1B Receptor stimulates vasoconstriction
  • 5HT-1D Receptor inhibits pre-synaptic release of CGRP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Triptan prototype

A

Sumatriptan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Sumatriptan–p.o.

A
  • Cmax=1-2 hours
  • 15% bioavailability–unreliable in some patients
  • clearance-t/12=1-2 hours
19
Q

Sumatriptan-other delivery options

A
  • SC-Cmax=15 minutes

- nasal spray=30 minutes

20
Q

Sumatriptan-metabolized by

21
Q

Other triptans

A
  • Almotriptan
  • Naratriptan-70% bioavailability; t/12 is 6 hours
  • Zolmitriptan–active metabolite
  • Rizatriptan
  • Eletriptan
  • Frovatriptan–t1/2=24 hours
22
Q

choice of delivery route

A
  • oral-easy to take, ineffective if patient vomits
  • nasal spray–effective with vomiting, simple, works quickly; few triptans formulated as nasal sprays
  • injection–works quickly; inconvenient
23
Q

Sumatriptan–delivery options

A
  • injectable subcutaneous
  • nasal spray
  • tablets
24
Q

Zolmmitriptan-delivery options

A
  • tablets
  • orally disintegrating tablets
  • nasal spray
25
Quick onset--what delivery options
- nasal spray--fast | - subcutaneous--sumatriptan fastest
26
is patient taking other medications? consider?
- serotonin syndrome | - MAO interactions
27
Triptans--contraindications
- ischemic/vasospastic coronary disease - cardiovascular disorder - uncontrolled hypertension
28
contraindicated in patients taking MAO inhibitors
-Sumatriptran -rizatriptan -zolmitriptan (metabolized by MAO)
29
used for severe or refractory migraine
-ergot alkaloids
30
Ergot alkaloids
- Dihydroergotamine - Ergotamine and caffeine * less specific!!
31
NEVER use what together??
triptan and DHE
32
Ergot alkaloids--side effects
- strong emetic action | - vasoconstriction--St. Anthony's fire
33
migraine treatment in pregnancy
- acetaminophen and codeine - aspirin-1 and 2nd trimester only - ibuprofen--1st and 2nd trimester only - triptans-cautiously
34
migraine treatment in pregnancy--contraindicated
- DIhydroergotamine | - Other ergot alkaloids
35
Botox and migraines?
- inhibits ACh release at motor endplates--reduce m activity | - not approved for migraines unless migraine isn't received from other meds
36
preventive agents--taken daily, asymptomatic
- B blockers - Tricyclic antidepressants - Anticonvulsants - Ca channel blockers
37
B blockers mechanism
- propranolol, timolol - anxiolytic action - decrease sympathetic activity - blunts cortical spreading depression * effective in 60-80%
38
B blockers--cautions
- Normal well tolerated | - bronchoconstriction--contraindicated in asthma patients
39
Tricyclic antidepressants
-amitriptylene, imipramine
40
anticonvulsants
-topiramine, valproate
41
Ca channel blockers
verapramil
42
considerations for preventative therapy
- >2 migraines per month with disability - disability lasting >3 days per month - adverse effects from acute treatments - rescue medication used >2x per week - uncommon migraine conditions
43
Ca channel blockers for migraine prevention--mechanism
- Verapamil - Lessens Ca dependent vesicle fusion - normalizes vessel tone